This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Klaus Bosslet, PhD
Managing Director at TheraPharm Deutschland GmbH


Klaus Bosslet earned his Ph.D in 1980 at the University of Heidelberg/ German Cancer Research Center (DKFZ) in the field of Tumour Immunology.

His professional career is dedicated to R+D in Oncology. He worked in cellular immunology, monoclonal antibodies, imaging, antibody enzyme fusion proteins, Pro-drug activation systems, signaling, cytolytic fusion proteins and finally in antibody targeted radio therapy.

Klaus has published more than 115 publications.

His last 3 industry positions preceding the actual position as managing Director at TheraPharm Deutschland GmbH were:

  • Site Head Discovery Oncology, Roche Pharmaceuticals – (2011-2015)
  • Global VP Oncology Research, MedImmune – (2008-2010)
  • Global Head Therapeutic Research Oncology, Schering AG/Bayer Schering Pharma – (1998-2008